Malassezia restricta Pneumonia in Solid Organ Transplant Recipients: First Report of Two Cases

Alessandra Mularoni1, Elena Graziano1,2, Alice Annalisa Medaglia3

  • 1Department of Infectious Diseases, IRCCS-ISMETT (Mediterranean Institute for Transplantation and Advanced Specialized Therapies), 90127 Palermo, Italy.

Insights

Emerging fungal infections pose significant risks for solid organ transplant recipients. This report details two successful treatments of Malassezia restricta pneumonia in these patients, highlighting effective antifungal therapy.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Transplantation Medicine

Background:

  • Emerging fungal infections present a substantial clinical challenge in solid organ transplantation (SOT).
  • These infections are frequently linked to increased patient morbidity and mortality rates.
  • Early diagnosis and prompt treatment are crucial for improving outcomes in SOT recipients.

Observation:

  • Two cases of pneumonia caused by Malassezia restricta were identified in solid organ transplant recipients.
  • The diagnosis was confirmed through a combination of molecular analysis and histological examination.
  • Both patients presented with symptoms indicative of a severe respiratory infection.

Findings:

  • Molecular and histological analyses confirmed Malassezia restricta as the causative agent.
  • Both SOT recipients received targeted antifungal therapy.
  • The patients demonstrated a complete recovery following treatment.

Implications:

  • This case report underscores the importance of considering Malassezia species in the differential diagnosis of pneumonia in SOT patients.
  • Effective antifungal treatment can lead to successful patient recovery.
  • Further research into the epidemiology and management of Malassezia infections in immunocompromised populations is warranted.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
384
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
389
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
567